Skip to main navigation Skip to search Skip to main content

Dupuytren’s Disease: Harnessing cutting-edge technologies to understand how genetic variants lead to clinically relevant changes in cellular phenotype.

Project Details

StatusActive
Effective start/end date1/02/2631/01/29

Funding

  • Action Arthritis (Norwich Hip Trust): £60,000.00